| Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load V Calsolaro, PM Matthews, CK Donat, NR Livingston, GD Femminella, ... Molecular psychiatry 26 (10), 5848-5855, 2021 | 56 | 2021 |
| Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects? GD Femminella, NR Livingston, S Raza, T Van Der Doef, E Frangou, ... Alzheimer's research & therapy 13, 1-11, 2021 | 41 | 2021 |
| Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired … NR Livingston, V Calsolaro, R Hinz, J Nowell, S Raza, S Gentleman, ... Molecular psychiatry 27 (4), 2019-2029, 2022 | 28 | 2022 |
| Evaluation of liraglutide in the treatment of Alzheimer's disease P Edison, GD Femminella, CW Ritchie, C Holmes, Z Walker, BH Ridha, ... Alzheimer's & Dementia 17, e057848, 2021 | 22 | 2021 |
| Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis NR Livingston, A De Micheli, RA McCutcheon, E Butler, M Hamdan, ... Schizophrenia Bulletin, sbae036, 2024 | 2 | 2024 |
| Letter to the Editor on ‘Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis’ NR Livingston, P Fusar-Poli, G Modinos Psychological medicine 54 (1), 215-216, 2024 | 1 | 2024 |
| Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis NR Livingston, A Kiemes, GA Devenyi, S Knight, PB Lukow, LA Jelen, ... Neuropsychopharmacology, 1-11, 2024 | | 2024 |
| Preliminary evidence for the PDE4-inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia N Livingston, J Gilleen, P Hawkins, S Shergill, M Mehta JOURNAL OF PSYCHOPHARMACOLOGY, 2021 | | 2021 |
